TREM2 and Alzheimer disease: Another effector involved in lipid metabolism and implicated in AD pathogenesis, triggering receptor expressed on myeloid cells 2 (TREM2), is expressed in microglia and mediates extracellular lipid sensing (Deczkowska et al., 2020).